ANXA2P2 is a potential immunological and prognostic signature gene, impacting the pathogenies and prognosis of ovarian serous cystadenocarcinoma and hepatocellular carcinoma [29,30], and functioning in the progression of glioblastoma [31]. The gene discussed is ANXA2P2; the disease is ovarian serous cystadenocarcinoma.